> A recent study, by a team of economists from the Wharton School, Notre Dame, and rand, reviewed overdose statistics in five states where Purdue opted, because of local regulations, to concentrate fewer resources in promoting its drug. The scholars found that, in those states, overdose rates—even from heroin and fentanyl—are markedly lower than in states where Purdue did the full marketing push. The study concludes that “the introduction and marketing of OxyContin explain a substantial share of overdose deaths over the last two decades.”
Right now people have no problem suppressing research they don't like about the negative effects of marijuana or anti-depressants or whatever their de jour personal treatment is - in 20 years if something bad really comes to light everyone is going to pretend that they knew all along and that everything was a smoking gun. Hindsight is 20/20 and history is written by the victors.
It’s worth skimming through the Massachusetts AG complaint about their actions, and the strategies employed by Purdue (of which the Sacklers always held the majority of board seats)
https://www.reuters.com/investigates/special-report/assets/u...
> Although a different formulation of oxycodone, manufactured by Merck & Co., was removed from the market in 1990 because of a high risk of addiction, members of the Sackler family downplayed the dangers of OxyContin, deceiving doctors into thinking that it was weaker than morphine and convincing them to prescribe the drug liberally